These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 33141807)

  • 21. Prognostic markers for the clinical course in the blood of patients with SARS-CoV-2 infection.
    Fischer JC; Balz V; Jazmati D; Bölke E; Freise NF; Keitel V; Feldt T; Jensen BO; Bode J; Lüdde T; Häussinger D; Adams O; Schneider EM; Enczmann J; Rox JM; Hermsen D; Schulze-Bosse K; Kindgen-Milles D; Knoefel WT; van Griensven M; Haussmann J; Tamaskovics B; Plettenberg C; Scheckenbach K; Corradini S; Pedoto A; Maas K; Schmidt L; Grebe O; Esposito I; Ehrhardt A; Peiper M; Buhren BA; Calles C; Stöhr A; Gerber PA; Lichtenberg A; Schelzig H; Flaig Y; Rezazadeh A; Budach W; Matuschek C
    Eur J Med Res; 2022 Nov; 27(1):255. PubMed ID: 36411478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA genetic polymorphism in patients with Coronavirus Disease 2019 in Midwestern United States.
    Schindler E; Dribus M; Duffy BF; Hock K; Farnsworth CW; Gragert L; Liu C
    HLA; 2021 Oct; 98(4):370-379. PubMed ID: 34338446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19.
    Schönfelder K; Breuckmann K; Elsner C; Dittmer U; Fistera D; Herbstreit F; Risse J; Schmidt K; Sutharsan S; Taube C; Jöckel KH; Siffert W; Kribben A; Möhlendick B
    Cytokine; 2021 Jun; 142():155492. PubMed ID: 33711707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19.
    Castro-Santos P; Rojas-Martinez A; Riancho JA; Lapunzina P; Flores C; Carracedo Á; Díaz-Peña R;
    HLA; 2023 Dec; 102(6):731-739. PubMed ID: 37528566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA genetic polymorphisms and prognosis of patients with COVID-19.
    Lorente L; Martín MM; Franco A; Barrios Y; Cáceres JJ; Solé-Violán J; Perez A; Marcos Y Ramos JA; Ramos-Gómez L; Ojeda N; Jiménez A; ;
    Med Intensiva (Engl Ed); 2021 Mar; 45(2):96-103. PubMed ID: 32988645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of human leukocyte antigen polymorphisms with occult hepatitis B virus infection in a Shaanxi Han population.
    Wang T; Shen C; Chen L; Liu S; Ji Y
    J Gene Med; 2017 Sep; 19(9-10):. PubMed ID: 28940887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.
    Requena D; Médico A; Chacón RD; Ramírez M; Marín-Sánchez O
    Front Immunol; 2020; 11():2008. PubMed ID: 33013857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19).
    Wang W; Zhang W; Zhang J; He J; Zhu F
    HLA; 2020 Aug; 96(2):194-196. PubMed ID: 32424945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019.
    Bernal E; Gimeno L; Alcaraz MJ; Quadeer AA; Moreno M; Martínez-Sánchez MV; Campillo JA; Gomez JM; Pelaez A; García E; Herranz M; Hernández-Olivo M; Martínez-Alfaro E; Alcaraz A; Muñoz Á; Cano A; McKay MR; Muro M; Minguela A
    J Infect Dis; 2021 Jul; 224(2):229-240. PubMed ID: 33928374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G.
    Mocci S; Littera R; Chessa L; Campagna M; Melis M; Ottelio CM; Piras IS; Lai S; Firinu D; Tranquilli S; Mascia A; Vacca M; Schirru D; Lecca LI; Rassu S; Cannas F; Sanna C; Carta MG; Sedda F; Giuressi E; Cipri S; Miglianti M; Perra A; Giglio S
    Front Immunol; 2023; 14():1138559. PubMed ID: 37342325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The humoral and cellular response to mRNA SARS-CoV-2 vaccine is influenced by HLA polymorphisms.
    Bertinetto FE; Magistroni P; Mazzola GA; Costa C; Elena G; Alizzi S; Scozzari G; Migliore E; Galassi C; Ciccone G; Ricciardelli G; Scarmozzino A; Angelone L; Cassoni P; Cavallo R; Vaisitti T; Deaglio S; Amoroso A;
    HLA; 2023 Sep; 102(3):301-315. PubMed ID: 37010080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility and Severity of COVID-19 Are Both Associated With Lower Overall Viral-Peptide Binding Repertoire of HLA Class I Molecules, Especially in Younger People.
    Basir HRG; Majzoobi MM; Ebrahimi S; Noroozbeygi M; Hashemi SH; Keramat F; Mamani M; Eini P; Alizadeh S; Solgi G; Di D
    Front Immunol; 2022; 13():891816. PubMed ID: 35911710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Immunogenetics in COVID-19.
    Pojero F; Candore G; Caruso C; Di Bona D; Groneberg DA; Ligotti ME; Accardi G; Aiello A
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between ABO Blood Group Phenotype and the Risk of COVID-19 Infection and Severity of Disease in a Saudi Arabian Cohort.
    Jawdat D; Hajeer A; Massadeh S; Aljawini N; Abedalthagafi MS; Alaamery M
    J Epidemiol Glob Health; 2022 Mar; 12(1):85-91. PubMed ID: 34978705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A model integrating Killer Immunoglobulin-like Receptor (KIR) haplotypes for risk prediction of COVID-19 clinical disease severity.
    Beksac M; Akin HY; Gencer-Oncul EB; Yousefzadeh M; Cengiz Seval G; Gulten E; Akdemir Kalkan I; Cinar G; Memikoglu O; Karaagaoglu E; Dalva K
    Immunogenetics; 2021 Dec; 73(6):449-458. PubMed ID: 34536086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms.
    Saulle I; Vicentini C; Clerici M; Biasin M
    Hum Immunol; 2021 Aug; 82(8):551-560. PubMed ID: 34116863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohort.
    Roll GR; Bray RA; Cooper M; Eagar TN; Gebel HM; Vranic GM; Hitchman KMK; Houp J; Kamoun M; Killian J; Kim J; Kumar V; Levine M; Lovasik BP; Lunow-Luke T; Parsons RF; Pattanayak V; Ranch D; Shah A; Stock PG; Timofeeva OA; Trofe-Clark J; Wongjirad C; Yeh H; Yi S; Rajalingam R
    Hum Immunol; 2023 Apr; 84(4):278-285. PubMed ID: 36868898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood system ABO antigens as risk factor for severity of SARS-CoV-2 infection.
    Torres-Alarcón CG; García-Ruíz A; Cañete-Ibáñez CR; Morales-Pogoda II; Muñoz-Arce CM; Cid-Domínguez BE; Montalvo-Bárcenas M; Torre GM; Sandoval-López C; Gaytán-Guzmán E; Correo-Zamora JD
    Gac Med Mex; 2021; 157(2):174-180. PubMed ID: 34270530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk HLA alleles in South America and potential new epitopes for SARS-CoV2.
    Sáenz Hinojosa S; Romero V
    Hum Immunol; 2021 Aug; 82(8):561-567. PubMed ID: 33972137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA Allele Frequencies and Association with Severity of COVID-19 Infection in Northern Italian Patients.
    Guerini FR; Bolognesi E; Lax A; Bianchi LNC; Caronni A; Zanzottera M; Agliardi C; Albergoni MP; Banfi PI; Navarro J; Clerici M
    Cells; 2022 May; 11(11):. PubMed ID: 35681490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.